Autonomix Medical, Inc.

During the period covered by this Quarterly Report, none of our directors or executive officers have adopted or terminated a Rule10b5-1 trading arrangement or a non-Rule10b5-1 trading arrangement (each as defined in Item408 of Regulation S-K under the Securities Exchange Act of1934, as amended).

In* July 2025,we entered into stock option cancellation agreements with certain employees to cancel an aggregate of57,331* stock options. Employees that elected to cancel their stock options were granted severance agreements for three,six ornine months of their base salary (under certain conditions). On* August 11, 2025,we entered into stock option cancellation agreements with Board members and certain officers of the Company to cancel an aggregate of177,652* stock options. Our Board members included Mr. Walter Klemp, Chairman of the Board; Ms. Lori Bisson, Executive Chair of the Board; and Mr. Chris Capelli, Director, respectively, and included amounts of8,773; 65,542; and3,750, respectively. Our officers included Mr. Brad Hauser, Chief Executive Officer and President; Mr. Landy Toth, Chief Technology Officer; Mr. Robert Schwartz, Chief Medical Officer; and Mr. Trent Smith, Chief Financial Officer, respectively, and included amounts of45,000; 8,773; 13,159; and32,655, respectively. Mr. Hauser was grantedthree months of his base salary, in addition to thetwelve months of his base salary per his* July 17, 2024employment agreement. Mr. Toth and Mr. Schwartz were granted severance agreements that amounted tonine* months of their base salary. Mr. Smith was grantedthree months of his base salary, in addition to thenine months of his base salary per his* July 24, 2023*employment agreement.

On* August 12, 2025,the Board of Directors of the Company adopted an Amended and Restated Bylaws (as amended and restated, the “Bylaws”), effective on such date. The sole change to the Bylaws was to revise Section2.07* of the Bylaws to reduce the number of shares of Company stock required to constitute a quorum at a meeting of stockholders from a majority of the voting power issued and outstanding and entitled to vote, present in person or by remote communication, if applicable, or represented by proxy, toone-third of the voting power issued and outstanding and entitled to vote, present in person or by remote communication, if applicable, or represented by proxy.